Oral Oncology
Volume 39, Issue 7 , Pages 701-707 , October 2003

Study on chemosensitivity of oral squamous cell carcinomas by histoculture drug response assay

  • Yasunori Ariyoshi

      Affiliations

    • Department of Oral Surgery, Osaka Medical College, 2-7 Daigakumachi Takatsuki city, Osaka, 569-8686, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-66-72-683-1221; fax: +81-66-72-684-6538
    • ,
  • Masashi Shimahara

      Affiliations

    • Department of Oral Surgery, Osaka Medical College, 2-7 Daigakumachi Takatsuki city, Osaka, 569-8686, Japan
    • ,
  • Nobuhiko Tanigawa

      Affiliations

    • Department of General and Gastroenterological Surgery, Osaka Medical College, 2-7 Daigakumachi Takatsuki city, Osaka, 569-8686, Japan

Received 4 April 2003 ,Accepted 8 April 2003.

References 

  1. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratsuka H. Mode of bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer. 1983;51:2175–2180
  2. Spiro RH, Guillamondegui O, Paulino AF, Huvos AG. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head & Neck. 1999;21:408–413
  3. Furukawa T, Kubota T, Hoffman RM. Clinical applications of the histoculture drug response assay. Clin Cancer Res. 1995;1:305–311
  4. Furukawa T, Kubota T, Watanabe M, Takahara T, Yamaguchi H, Takeuchi T, et al.  High in vitro–in vivo correlation of drug response using sponge-gel-supported three-dimensional histoculture and the MTT end point. Int. J. Cancer. 1992;51:489–498
  5. Tanino H, Kubota T, Oura S, Yamamichi N, Suzuma T, Yoshimusu T, et al.  Histoculture drug response assay for identification of active agents in multidrug resistant recurrent breast cancer. Jpn J Breast Cancer. 1998;13:719–725
  6. Sakurai T, Tanino H, Oura S, Suzuma T, Yamamiti N, Yoshimasu T, et al.  Efficacy of docetaxel for recurrent breast cancer: evaluation based on chemosensitivity test and clinical response. Jpn J Cancer Chemothr. 2000;27:423–427
  7. Cortazar P, Johnson BE. Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol. 1999;17:1625–1631
  8. Mosmann T. Rapid colorimetric assay for cellular growth and survival (application of proliferation and cytotoxicity assays). J Immunol Methods. 1983;65:55–63
  9. Suto A, Kubota T, Shimoyama Y, Ishibiki K, Abe O. MTT assay with reference to the clinical effects of chemotherapy. J Surg Oncol. 1989;42:28–32
  10. Freeman AE, Hoffman RM. In vivo-like growth of human tumors in vitro. Proc. Natl. Acad. Sci. USA. 1986;83:2694–2698
  11. Sigh B, Li R, Xu L, Poluri A, Patel S, Shara AR, et al.  Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head & Neck. 2002;24:437–442
  12. Maehara Y, Anai H, Kusumoto H, Sugimaci K. Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma. Eur J Surg Oncol. 1987;13:203–206
  13. Cline MJ, Haskell CM. Cancer chemotherapy. 3rd ed. Philadelphia: W.B.Saunders; 1980;
  14. Nakashima T, Uemura T, Maehara Y, Sugimachi K. Succinate dehydrogenase inhibition test for evaluating head and neck tumors. Oncology. 1989;46:162–168
  15. Sunakawa H, Yamamoto E. Clinico-pathological studies on squamous cell carcinoma in the oral region—quantitative analysis on effect of cancer chemotherapy with bleomycin. Sapporo Ishi. 1983;2:531–557
  16. Nakashima T, Maehara Y, Kohnoe S, Hayashi I, Katsuta Y. Histologic differentiation and chemosensitivity of human head and neck squamous cell carcinomas. Head & Neck. 1990;12:406–410
  17. Kubota T, Sasano N, Abe O, Nakao I, Kawamura E, Saito T, et al.  Potential of the histoculture drug-response assay to contribute to cancer patients survival. Clin Cancer Res. 1995;1:1537–1543
  18. Robbins T, Connors KM, Storniolo AM, Hanchett C, Hoffman RM. Sponge-gel supported histoculture drug response assay for head and neck cancer (Correlations with clinical response to cisplatin). Arch Otol Head Neck Surg. 1994;120:288–292

PII: S1368-8375(03)00082-4

doi: 10.1016/S1368-8375(03)00082-4

Oral Oncology
Volume 39, Issue 7 , Pages 701-707 , October 2003

Article Tools

* Image Usage & Resolution